Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03067584 · ClinicalTrials.gov registry record

Genetic Study of Familial Acute Lymphoblastic Leukemia

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
4
Enrollment target

NCT03067584 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03067584 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
4 participants
Enrollment target

Study Summary

Familial aggregation is well recognized in some cancers. Though a number of familial cancer predisposition syndromes have been described, the nature of inherited genetic alterations in patients with a strong history of familial cancer is currently unknown, as is the case with childhood acute lymphoblastic leukemia (ALL). The investigators are seeking to learn more about what causes leukemia and why some people and families may be at a higher risk of developing this disease. By understanding the origin of the disease, better treatments may be identified for patients with leukemia. PRIMARY OBJECTIVE: To identify variants in genes that are inherited, have altered gene structure and/or function, and influence the risk of developing acute lymphoblastic leukemia (ALL) and other cancers. SECONDARY OBJECTIVE: To collect demographic, clinical and laboratory information including detailed family cancer history and response of cancers to therapy for correlation with the primary objective.

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2017-05-09
Est. Completion 2017-06-23

What the Registry Record Tells You About NCT03067584

The ClinicalTrials.gov registry entry for NCT03067584 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03067584 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03067584 about?

NCT03067584 is a clinical study titled "Genetic Study of Familial Acute Lymphoblastic Leukemia". Familial aggregation is well recognized in some cancers. Though a number of familial cancer predisposition syndromes have been described, the nature of inherited genetic alterations in patients with a strong history of familial cancer is currently unknown, as is the case with childhood acute lymphob...

What is the current status of trial NCT03067584?

This trial is currently completed. The enrollment target is 4 participants. The study started on 2017-05-09. Estimated completion is 2017-06-23.

Who is sponsoring clinical trial NCT03067584?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.